Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?

Connecticut-based fund Braidwell established a new position in ACADIA Pharmaceuticals (NASDAQ:ACAD), adding nearly 2.4 million shares, a stake valued at about $50.8 million as of September 30.According to a filing with the U.S. Securities and Exchange Commission dated November 14, Braidwell disclosed a new stake in ACADIA Pharmaceuticals, acquiring nearly 2.4 million shares valued at approximately $50.8 million as of September 30. The addition accounted for 2.1% of the fund’s total reportable U.S. equity assets for the quarter.Top holdings after the filing:  Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool